The platelet aggregate ratio has been found to be decreased in some patients with 
Introduction
Wu and his colleagues described the platelet aggregate ratio as an index of circulating platelet aggregates and reported it to be decreased in some patients with occlusive vascular diseases (Wu and Hoak, 1974, 1975; Wu, Barnes and Hoak, 1976) . Their method is based on the ratio of the platelet count of platelet-rich plasma prepared from blood mixed with a solution of EDTA and formaldehyde Requests for reprints: Dr James W. Davis Wu and Hoak (1974) that the platelet aggregate ratio of rabbits decreased after the i.v. infusion of thrombin, suggested that this ratio monitored the presence of platelet aggregates circulating in vivo. However, Rohrer et al. (1978a) found that the platelet aggregate ratio of normal human venous blood samples varied with the rate of blood flow into the needle, suggesting that platelet aggregates formed in the needle and tubing may affect the platelet aggregate ratio. Subsequently, the platelet aggregate ratio was reported to be highly correlated with 3-thromboglobulin (Chen et al., 1979) and to decrease in association with an increase in the plasma concentration of platelet factor 4 after exhaustive exercise (Levine et al., 1979) . This suggests a relationship of the platelet aggregate ratio to secretion of the contents of a-granules from platelets (Kaplan et al., 1979) . The observation in patients with ischaemic heart disease of a high correlation between the platelet aggregate ratio and the platelet half-life in vivo is evidence supporting the interpretation of the platelet aggregate ratio as an index of circulating platelet aggregates in such patients (Salem, Koutts and Firkin, 1980 Platelet aggregate ratios were determined essentially as described by Wu (1978) . A first sample of antecubital venous blood was drawn into a plastic syringe containing a buffered solution of EDTA and formaldehyde and a second sample into another syringe containing a buffered solution of EDTA without formaldehyde. The contents of the syringes were immediately mixed by inverting 3 times, then transferred to siliconized glass tubes and incubated at room temperature for 15 min before centrifugation at 220 g (bottom of tube) for 8 min. The supernatants were diluted 1: 20 in 1 % ammonium oxalate for platelet counting by phase-contrast microscopy using duplicate pipettes. The ratio of the platelet count in the supernatant containing formaldehyde to that without formaldehyde was calculated.
The significance of the differences between mean platelet aggregate ratios and mean serum cholesterol concentrations was determined by the Wilcoxon rank sum test. The Spearman rank correlation coefficient was used to determine the association of the platelet aggregate ratio with age and serum cholesterol concentration.
Results
The fasting serum cholesterol concentrations of the 52 patients studied ranged from 135 to 360 mg/dl. The mean platelet aggregate ratios (±s.d.) of the 26 men with the lowest serum cholesterol concentrations (135-225 mg/dl) and of the 26 men with the highest serum cholesterol concentrations (230-360 mg/dl) were 0.79±0 17 and 0.78±0.13 respectively (P>0.1). The platelet aggregate ratio correlated poorly with the fasting serum cholesterol concentration (r=0-06; P=0'7) and with the age (r=0-03; P> 0'9) of the 52 men.
The subjects included 31 habitual smokers of tobacco products (mostly cigarettes) and 21 nonsmokers. The mean platelet aggregate ratio (± s.d.) of the smokers was 0-76±00-16 and of the nonsmokers was 081 4-0-14 (P>0-1). The mean fasting serum cholesterol (i± s.d.) of the 31 smokers (whose mean age was 55 years) was 227 ±52 mg/dl and of the 21 non-smokers (whose mean age was 58 years) was 243 ±52 mg/dl (P > 0 1).
Discussion
It has been reported (Carvalho, Colman and Lees, 1974) Although in 2 studies before 1960 (Thomas, 1958; Karvonen et al., 1959) men who smoked tobacco had higher serum concentrations of total cholesterol than did non-smokers, results are in agreement with those of 2 more recent studies (Pozner and Billimoria, 1970; Enger et al., 1977) which showed the mean serum cholesterol concentration of male smokers to be no higher than that of non-smokers. Erikssen, Hellem and Stormorken (1977) found a small but highly statistically significant increase in 'platelet adhesiveness' in smokers as compared with non-smokers when the former were tested at least 12 hr after the last cigarette was smoked. After finding that the mean platelet aggregate ratios of 2 groups of healthy volunteers decreased during a 20-min period in which 2 cigarettes were smoked Davis, 1979, 1980) , the authors analysed the present series of 52 men to see whether the 31 habitual smokers had lower ratios than did the 21 non-smokers. This was found to be the case, but the difference was not statistically significant. Rohrer et al. (1978b) found a lower mean platelet aggregate ratio in normal smokers than in normal non-smokers, but the difference also was not statistically significant. The possibility of a prolonged effect of smoking on the platelet aggregate ratio is more strongly suggested by the mean platelet aggregate ratios of 20 healthy habitual smokers and 20 healthy non-smokers of similar age and sex distribution. The mean platelet aggregate ratio of the smokers, who were asked to abstain from smoking for at least 8 hr before determination of the platelet aggregate ratio, was 0 79 and of the non-smokers (Davis and Davis, 1980) was 091 (P<0-05). The platelet aggregate ratios of patients with a variety of thromboembolic conditions have been reported to be low by most workers (Wu and Hoak, 1974, 1975; Wu et al., 1976; Gjesdal, 1976; Dougherty, Levy and Weksler, 1977; Guyton and Willerson, 1977; Wu, 1978; Mehta and Mehta, 1979; Salem et al., 1980) and normal by others (Prazich et al., 1977; Rohrer et al., 1978b 
